Description:
Kalorama Information’s The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, Autoimmune, Others), 2021 provides an authoritative and comprehensive analysis of the global biomarker market from 2015 to 2024, with 2020 as the base year. This report covers the diverse applications of biomarkers in diagnostics, including disease diagnosis, prognosis prediction, therapy selection, disease monitoring, and more.
Market Segments:
The report offers detailed market data across key clinical diagnostic biomarker segments, including:
- Cancer Biomarkers: Evaluation of tumor markers and their role in cancer diagnosis and management.
- Cardiovascular Disease Biomarkers: Analysis of biomarkers for heart disease and vascular disorders.
- Immunological Disease Biomarkers: Insights into biomarkers for autoimmune diseases and allergies.
- Infectious Disease Biomarkers: Overview of biomarkers used to detect and manage infectious diseases.
- Neurological Disease Biomarkers: Examination of biomarkers for diseases affecting the nervous system.
- Other Disease Biomarkers: Coverage of biomarkers for various other conditions including bone diseases, renal diseases, and more.
Industry Trends and Innovations:
Understand the drivers of growth in the biomarker market, including:
- Aging Population: Increasing susceptibility to diseases in older populations.
- Targeted Therapies: Rise in the development and introduction of targeted therapies.
- Expanding Diagnostic Test Market: Growth in the clinical diagnostic test market fueling biomarker development.
- Technological Advances: Emerging technologies such as mass spectrometry, next-generation DNA sequencing, and bioinformatics.
Market Analysis:
Explore the global landscape of the biomarker market with a focus on:
- Total Global Clinical Diagnostic Biomarker Market: Market forecasts and growth rates for various disease segments from 2015 to 2025.
- Segment Analysis: Detailed data on market segments by disease and technology, highlighting the share of each segment.
Personalized and Precision Medicine:
Delve into the role of biomarkers in the evolution of personalized and precision medicine:
- Pharmacogenomics and Pharmacogenetics: Growth of companion diagnostics and their integration into clinical practice.
- Automation and Innovation: Advances in instrumentation and the introduction of new biomarker tests.
- Reimbursement Trends: Increasing acceptance and coverage for new biomarker-based diagnostics by healthcare payers.
Competitor Analysis:
Gain insights into key players in the biomarker market, including:
- Top Tier IVD Companies: Profiles of leading companies in the biomarker space.
- Specialized Biomarker Companies: Detailed reviews of companies focused on specific biomarker technologies and applications.
Detailed Company Profiles:
The report includes extensive profiles of companies active in the biomarker market, ranging from large multinationals to innovative startups. These profiles cover:
- Commercialized Products: Overview of products available in the market and in development.
- Key Technologies: Technologies used for biomarker detection and analysis, including immunoassays, PCR, microarrays, and more.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global Biomarker Sales, by Product Group & Region, 2018-2027 (million dollars)
Item/Year | 2018 | 2020 | 2022 | 2027 | CAGR (18-27) |
Product Groups | |||||
Infectious Diseases | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Cancer | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Cardiovascular | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Clinical Chemistry | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Neurological | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Autoimmune | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Other | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Regions | |||||
North America | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Western Europe | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Asia/Pacific | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Central & South America | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Eastern Europe | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Middle East | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Africa | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Total | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information